GeneDx Holdings Corp. (WGSWW)
NASDAQ: WGSWW · Real-Time Price · USD · Warrants
0.0897
+0.0025 (2.87%)
Jun 27, 2025, 9:53 AM - Market open
Company Description
GeneDx Holdings Corp., a genomics company, provides genetic testing services.
It primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
The company also develops an AI-based platform for NGS analysis, interpretation, and clinical reporting for rare disease, hereditary risk, and cancer testing.
The company is headquartered in Stamford, Connecticut.
GeneDx Holdings Corp.
| Country | United States |
| Founded | 2017 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 1,000 |
| CEO | Katherine Stueland |
Contact Details
Address: North Tower, 6th Floor Stamford, Connecticut 06902 United States | |
| Phone | 888 729 1206 |
| Website | genedx.com |
Stock Details
| Ticker Symbol | WGSWW |
| Exchange | NASDAQ |
| Stock Type | Warrants |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001818331 |
| ISIN Number | US81663L1199 |
Key Executives
| Name | Position |
|---|---|
| Katherine A. Stueland | President, Chief Executive Officer and Director |
| Kevin Feeley CPA | Chief Financial Officer |
| Dr. Bryan M. Dechairo Ph.D. | Chief Operating Officer |
| Heidi C. Chen J.D. | Chief Legal Officer |
| Jami Biliboaca | Head of People Strategy |
| Melanie Duquette | Chief Growth Officer |
| Dr. Martin G. Reese Ph.D. | President of Fabric Genomics |